LB Pharmaceuticals (LBRX) announced the appointment of Robert Lenz, M.D., Ph.D. to its Board of Directors.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LBRX:
- LB Pharmaceuticals management to meet with Piper Sandler
- LB Pharmaceuticals Announces $100 Million Private Placement Financing
- LB Pharmaceuticals prices 3.31M shares at $21.17 in private placement
- LB Pharmaceuticals Advances LB-102 Into Long-Term Phase 3 Safety Study for Schizophrenia
- LB Pharmaceuticals initiates Phase 2 trial of LB-102